
Video
A conversation with Hui Chen
- Video
- Global
- Creating a Compliant Organisation
A conversation with Hui Chen
Ethics and governance, crime and punishment
As the enforcement environment in the US is in the midst of uncertainty under a new administration, intensified by changing priorities in the DOJ, how should the compliance community navigate this unpredictable period for enforcement? What is the playing field now and how should companies approach it?
The webcast will cover the following
- What the compliance community should expect from the US and the DOJ
- The importance of measuring your own success and how to achieve this
- Top tips to navigate this period of unpredictability
- Charles Hecker, Senior Partner
- Hui Chen,Ethics and Compliance Speaker and Consultant
Authors
Author

Latest

Report
CORE political violence and violent organised crime report Q4 2020
We are pleased to release our forth quarter report on political violence and violent organised crime incidents around the world. This report draws upon and highlights the extensive incident mapping data and analysis that is available within CORE, the essential risk monitoring toolkit from Control Risks.

The Global Insight
The new American threat landscape
Join Charles Hecker and Control Risks experts Jonathan Wood and Shawn VanSlyke for a discussion about the implications of the 6 January storming of the US Capitol for the US security environment.

Analysis
RiskMap 2021: The legal and compliance perspective
As we move into 2021, legal and compliance teams – like the companies they work for – undoubtedly face challenges. Find out more about the five key issues for the upcoming year.

Analysis
2021 will change how private market investors consider deals
Our RiskMap coverage shows that dealmakers need to have a range of issues in mind as they consider transactions in 2021. Find out more about the three key considerations here.

The Global Insight
Vaccines: the road ahead
Join Charles Hecker and Control Risks experts Caroline Naumann and Joseph Smith for a conversation about the unique challenges facing the global rollout of COVID-19 vaccines.